A ray of hope in the discord: is adding piperacillin-tazobactam to vancomycin truly more nephrotoxic?

Intensive Care Med. 2022 Sep;48(9):1208-1210. doi: 10.1007/s00134-022-06861-4. Epub 2022 Aug 31.

Jean-Maxime Côté^{1

2}, Sandra L Kane-Gill^{3

4}, Patrick T Murray^{5

6}

¹ Division of Nephrology, Department of Medicine, Centre Hospitalier de L'Université de Montréal, Montréal, Canada.
² Clinical Research Center (CrCHUM), Centre Hospitalier de L'Université de Montréal, Montréal, Canada.
³ Department of Pharmacy and Therapeutics, Department of Pharmacy and Therapeutics, University of Pittsburgh, Pittsburgh, PA, USA.
⁴ Program for Critical Care Nephrology, Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
⁵ School of Medicine, University College Dublin, Dublin, Ireland. patrick.murray@ucd.ie.
⁶ Division of Nephrology, Mater Misericordiae University Hospital, Dublin, Ireland. patrick.murray@ucd.ie.

No abstract available

Publication types